Late last week CMS finally released its anticipated drug acquisition cost survey (“Survey”) to collect pricing data for certain directly reimbursable drugs called “Specified Covered Outpatient Drugs” that are subject to significantly reduced Medicare payment when acquired using a 340B Program discount (“SCODs” or “340B Drugs”). All hospitals enrolled in the 340B Program during the…Read More
Attention 340B Hospitals: CMS Cost Data Survey Due May 15 Raises Important Compliance Questions
Posted on May 1, 2020 in Health Law News
Published by: Hall Render